Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $8.1600 (-5.56%) ($8.1600 - $8.7800) on Fri. Jun. 16, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.34% (three month average) | RSI | 58 | Latest Price | $8.1600(-5.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 0.4% a day on average for past five trading days. | Weekly Trend | IOVA advances 0.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) XBI(41%) ACES(25%) IBB(25%) PEJ(25%) VFMO(25%) | Factors Impacting IOVA price | IOVA will decline at least -2.67% in a week (0% probabilities). XLU(-24%) UUP(-20%) XLP(-19%) SPLV(-18%) USO(-13%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.67% (StdDev 5.34%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $8.27 | 5 Day Moving Average | $8.4(-2.86%) | 10 Day Moving Average | $8.35(-2.28%) | 20 Day Moving Average | $8.27(-1.33%) | To recent high | -10.4% | To recent low | 52.1% | Market Cap | $1.195b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |